In Part II, Mark Lloyd, Executive Vice President and Founder of Inspirata, continues explaining Inspirata’s offerings that change the patient’s care pathway. Mark shares Inspirata’s origins, beginning with his passion for digital pathology and positively impacting the cancer patient’s journey. Mark describes Inspirata’s successful implementation at The Ohio State University and highlights Isilon as a key part. It resulted in the first primary digital diagnosis in the United States and the l...